Annual Accounts Payable
$5.62 M
+$3.06 M+119.70%
31 December 2023
Summary:
Cellectar Biosciences annual accounts payable is currently $5.62 million, with the most recent change of +$3.06 million (+119.70%) on 31 December 2023. During the last 3 years, it has risen by +$4.21 million (+297.17%). CLRB annual accounts payable is now -11.81% below its all-time high of $6.37 million, reached on 31 December 2007.CLRB Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
N/A
30 September 2024
Summary:
Cellectar Biosciences quarterly accounts payable is not available.CLRB Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLRB Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +297.2% | - |
| 5 y5 years | +339.8% | - |
CLRB Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +297.2% | ||
| 5 y | 5 years | at high | +339.8% | ||
| alltime | all time | -11.8% | +2557.2% |
Cellectar Biosciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $5.62 M(+119.7%) | $5.62 M(+119.7%) |
| Dec 2022 | $2.56 M(+80.8%) | $2.56 M(+80.8%) |
| Dec 2021 | $1.42 M(-1.0%) | $1.42 M(-1.0%) |
| Dec 2020 | $1.43 M(+11.8%) | $1.43 M(+11.8%) |
| Dec 2019 | $1.28 M(+108.8%) | $1.28 M(+108.8%) |
| Dec 2018 | $612.00 K(-34.4%) | $612.00 K(-34.4%) |
| Dec 2017 | $933.00 K(+95.2%) | $933.00 K(-8.7%) |
| June 2013 | - | $1.02 M(+18.4%) |
| Mar 2013 | - | $863.00 K(+80.5%) |
| Dec 2011 | $478.00 K(+21.7%) | $478.00 K(+8.2%) |
| Sept 2011 | - | $441.70 K(+20.7%) |
| June 2011 | - | $365.80 K(+46.3%) |
| Mar 2011 | - | $250.00 K(-36.4%) |
| Dec 2010 | $392.90 K(-88.1%) | $392.90 K(-49.0%) |
| Sept 2010 | - | $770.70 K(-43.0%) |
| June 2010 | - | $1.35 M(-53.3%) |
| Mar 2010 | - | $2.90 M(-12.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $3.30 M(-29.1%) | $3.30 M(-29.1%) |
| Dec 2008 | $4.65 M(-27.0%) | $4.65 M(-17.2%) |
| Sept 2008 | - | $5.62 M(-25.1%) |
| June 2008 | - | $7.50 M(-12.2%) |
| Mar 2008 | - | $8.55 M(+34.1%) |
| Dec 2007 | $6.37 M(+485.7%) | $6.37 M(+40.2%) |
| Sept 2007 | - | $4.55 M(+77.2%) |
| June 2007 | - | $2.57 M(+106.1%) |
| Mar 2007 | - | $1.25 M(+14.4%) |
| Dec 2006 | $1.09 M(+414.4%) | $1.09 M(-1.3%) |
| Sept 2006 | - | $1.10 M(+75.0%) |
| June 2006 | - | $629.70 K(+34.0%) |
| Mar 2006 | - | $469.90 K(+122.2%) |
| Dec 2005 | $211.50 K | $211.50 K(-69.3%) |
| Sept 2005 | - | $689.90 K(+259.5%) |
| June 2005 | - | $191.90 K(+229.7%) |
| Mar 2005 | - | $58.20 K |
FAQ
- What is Cellectar Biosciences annual accounts payable?
- What is the all time high annual accounts payable for Cellectar Biosciences?
- What is the all time high quarterly accounts payable for Cellectar Biosciences?
What is Cellectar Biosciences annual accounts payable?
The current annual accounts payable of CLRB is $5.62 M
What is the all time high annual accounts payable for Cellectar Biosciences?
Cellectar Biosciences all-time high annual accounts payable is $6.37 M
What is the all time high quarterly accounts payable for Cellectar Biosciences?
Cellectar Biosciences all-time high quarterly accounts payable is $8.55 M